PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Interview with Paul Rennie and Capital 51, page-6

  1. 570 Posts.
    lightbulb Created with Sketch. 42
    I thought PR did an excellent job in explaining

    ...where Paradigm are at
    ...the processes involved
    ....what 002, 003, 006 and 008 trials are
    ...timelines
    ...potential commercialisation opportunities etc

    ...all in a clear and concise way. I’m no expert at all but even I managed to follow this interview and feel like I’ve got a much better understanding of Paradigm and it’s potential.

    I highly recommend new Paradigmers or laymen listen to the interview. GLTAH
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.